Related Experiment Video
Updated: Sep 29, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Simulating Screening for Risk of Childhood Diabetes: The Collaborative Open Outcomes tooL (COOL)
Mohamed Ghalwash1, Eileen Koski1, Riitta Veijola2
1Center for Computational Health, IBM Research, NY, USA.
Abstract:
The Collaborative Open Outcomes tooL (COOL) is a novel, highly configurable application to simulate, evaluate and compare potential population-level screening schedules. Its first application is type 1 diabetes (T1D) screening, where known biomarkers for risk exist but clinical application lags behind. COOL was developed with the T1DI Study Group, in order to assess screening schedules for islet autoimmunity development based on existing datasets. This work shows clinical research utility, but the tool can be applied in other contexts. COOL helps the user define and evaluate a domain knowledge-driven screening schedule, which can be further refined with data-driven insights. COOL can also compare performance of alternative schedules using adjusted sensitivity, specificity, PPV and NPV metrics. Insights from COOL may support a variety of needs in disease screening and surveillance.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

